Article
Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Annals of neurology - 1 Jul 2017
Gadoth Avi, Pittock Sean J, Dubey Divyanshu, McKeon Andrew, Britton Jeff W, Schmeling John E, Smith Aurelia, Kotsenas Amy L, Watson Robert E, Lachance Daniel H, Flanagan Eoin P, Lennon Vanda A, Klein Christopher J
Abstract excerpt
OBJECTIVE: To describe an expanded phenotypic spectrum and longitudinal outcome in 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients. METHODS: Patients were identified through service neural autoantibody evaluation. Ninety-five had longitudinal follow-up (7-456 months; median = 35). RESULTS: Among 3,910 patients tested, 196 were LGI1-IgG positive, 51 were CASPR2-IgG positive, and 9 were dual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
